Belzutifan, CABOZANTINIB , Lenvatinib, Lenvatinib
MK-6482-011
Phase 3 small_molecule active
Quick answer
Belzutifan, CABOZANTINIB , Lenvatinib, Lenvatinib for Advanced RCC with clear cell component is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Advanced RCC with clear cell component
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active